EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Diagnostic Methods and Biomarkers in Inflammatory Bowel Disease

Andrew M Kaz iD, Nanda Venu

Diagnostics · 22.05.2025 · 15 (11) · 1303

DOI: 10.3390/diagnostics15111303 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 22.05.2025. Verfasst von Andrew M Kaz und 1 weiteren Autor:innen. Beteiligte Einrichtung: GI Section, Hospital and Specialty Medicine, VA Puget Sound Health Care System, Seattle, WA 98108, USA. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VA Puget Sound Health Care System.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) refers to a chronic inflammatory condition involving the GI tract that includes Crohn’s disease (CD) and ulcerative colitis (UC). These conditions are believed to arise in genetically predisposed individuals who develop an exaggerated immune response to the intestinal microbiota. A timely and accurate diagnosis of IBD is essential because diagnostic delays can result in intestinal damage that is irreversible, leading in some cases to intestinal dysfunction and the need for surgery. Diagnostic delays are common in cases when GI symptoms are mild and nonspecific. When IBD is suspected, the common diagnostic algorithm includes laboratory analyses, cross-sectional radiologic imaging, and endoscopy with biopsy and histological analysis. Other diagnostic biomarkers, including those found in the serum, stool, and urine, have also been evaluated in IBD. Newer artificial intelligence (AI)-based technologies are now being developed, and these will likely play an important future role in the diagnosis and management of IBD.

Schlagwörter

Stichwörter der Autor:innen

Crohn’s diseaseartificial intelligencebiomarkerdiagnosisendoscopyinflammatory bowel diseaseintestinal ultrasoundulcerative colitisvideo capsule endoscopy

Autor:innen und Institutionen

  • GI Section, Hospital and Specialty Medicine, VA Puget Sound Health Care System, Seattle, WA 98108, USA.
  • Department of Medicine/Gastroenterology, University of Washington School of Medicine, Seattle, WA 98195, USA.
  • Center for Digestive Health, Virginia Mason Franciscan Health, Seattle, WA 98101, USA.

ORCID-Profile: Andrew M Kaz

Förderung

  • VA Puget Sound Health Care System

Zitieren

APA

Kaz, A. M., & Venu, N. (2025). Diagnostic Methods and Biomarkers in Inflammatory Bowel Disease. Diagnostics, 15(11), 1303. https://doi.org/10.3390/diagnostics15111303

Vancouver

Kaz AM, Venu N. Diagnostic Methods and Biomarkers in Inflammatory Bowel Disease. Diagnostics. 2025;15(11):1303. doi:10.3390/diagnostics15111303

BibTeX
@article{Kaz2025,
  author = {Kaz, Andrew M and Venu, Nanda},
  title = {Diagnostic Methods and Biomarkers in Inflammatory Bowel Disease},
  journal = {Diagnostics},
  year = {2025},
  volume = {15},
  number = {11},
  pages = {1303},
  doi = {10.3390/diagnostics15111303}
}
Kostenlos starten →